Cite
HARVARD Citation
Shindo, T. et al. (2022). Are there differences in the characteristics of patients who respond to gemcitabine plus cisplatin chemotherapy and those who respond to pembrolizumab therapy for metastatic urothelial carcinoma? Multicenter retrospective study. International journal of urology. pp. 1010-1016. [Online].